New Options For Trading Astrazeneca

Astrazeneca is off its 52 week high after rebuffing offers from Pfizer this month. In its final proposal announcement, Pfizer announced a possible offer comprising, for each AstraZeneca share, 1.747 shares in the combined entity and 2,476 pence in cash, representing an indicative value of £55.001. Shares of AZN are trading at $72.67 this morning versus a 52 week high of $82.68.

Related Videos

  • Pfizer Abandons AstraZeneca Bid But Its Tax Issues Live On

    So another multi-billion dollar proposed merger between corporate giants is kaput. Pfizer announced on Monday it is abandoning its unsolicited bid to acquire British pharmaceutical company AstraZeneca after the company rejected its offers four times. A less obvious ramification of the proposed deal, though, still must play out even though Pfizer is throwing in the towel: namely Pfizer’s bid infuriated many in Congress because it would allow the company to reincorporate in the U.K.

  • Pfizer Says It Won't Make Offer For AstraZeneca

    Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca. The announcement Monday comes a week after AstraZeneca's board rejected a proposed $119 billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue. Pfizer Chairman and CEO Ian Read says the company's final proposal represented full value for AstraZeneca, saying their businesses would be stronger together.

  • AstraZeneca Rejects Pfizer New Offer of $120 Billion

    After AstraZeneca rejected what U.S. peer Pfizer said was its final increased offer, what's next in Pfizer's quest for the company? Dana Cimilluca joins MoneyBeat.

  • Pfizer Drops Pursuit Of AstraZeneca

    Pfizer quit its months-long pursuit of rival AstraZeneca Monday, officially declaring it does not intend to make a new offer after the British drugmaker's rejection of its $119 billion bid last week. Pfizer had described its latest offer as final and said it would not pursue a hostile deal if AstraZeneca declined to open formal negotiations. After it was rebuffed, Pfizer went public with a $100 billion cash-and-stock offer for the company in late April.

  • Pfizer Offered $99 Billion In AstraZeneca Bid

    Pfizer confirmed today that it had asked AstraZeneca to consider a merger, and been rebuffed. Under U.K. law, it had to disclose the offer and went public with a $98.7 billion offer to buy the London-based drug maker. The deal will be 70% cash and 30% stock, and will provide Pfizer with a way to use funds it has kept out of the U.S. without paying U.S. taxes. The deal would also allow Pfizer to lower its tax rate by creating a holding company in the U.K.

  • Pfizer Prepares Sweeter Bid For AstraZeneca

    Pfizer may sweeten its offer for Britain's AstraZeneca Plc to more than 63 billion pounds, or $106 billion, and raise the cash portion of the deal, to kickstart negotiations, Bloomberg reported on Thursday. Citing people with knowledge of the matter, the report said a new bid may value AstraZeneca at more than 50 pounds per share and could come as early as next week. Pfizer disclosed earlier this week that it had twice approached AstraZeneca about a takeover, only to be rebuffed in both cases.

  • Pfizer Walks Away From $118 Billion AstraZeneca Deal

    Pfizer said on Monday it had abandoned its current attempt to buy AstraZeneca for nearly $118 billion as a deadline approached without a last-minute change of heart by the British drugmaker. "Following the AstraZeneca board's rejection of the proposal, Pfizer announces that it does not intend to make an offer for AstraZeneca," Pfizer said in a short news release.

  • Britain's AstraZeneca Rejects 'Final' Pfizer Bid

    British drug maker AstraZeneca rejected Monday what its New York-based rival Pfizer called over the weekend its "final" takeover offer. In a statement, AstraZeneca's board cited the "uncertainty and risks" for shareholders as a reason for the rejection, which came just hours after the maker of the erectile-dysfunction drug Viagra had upped the value of its bid to about $93 a share in a deal that would have led to the world's largest drugs company.

  • Pfizer Needs AstraZeneca More Than Ever as Generics Increase

    Pfizer shares are slipping after the drug maker posted first-quarter profits 15 percent lower than a year earlier and revenue down 9 percent. Net income of 57 cents a share beat expectations by 2 cents, but $11.3 billion in sales fell short of analysts' estimates of $12.1 billion. The weaker-than-expected report comes days after its latest offer to purchase British drug maker AstraZeneca for $106 billion was rejected.

  • AstraZeneca Falls After Pfizer Retreats and More Business News

    Corporate transactions provide the main impetus in European trading on Tuesday in the absence of significant economic data. AstraZeneca loses more ground after Pfizer officially pulled its $116.9 billion takeover proposal. InterContinental Hotels Group surges following a report it has received and rejected a $10 billion bid from as mystery U.S. suitor keen to cut its tax bill.

  • Clock Ticking For Pfizer To Raise AstraZeneca Bid

    Pfizer is considering raising its offer for AstraZeneca as it works with its advisers against the clock in a battle where they have just eight days left to move under British takeover rules. People familiar with the matter said, that Pfizer still hopes to get AstraZeneca into negotiations before the May 26 deadline for it to make a formal bid or walk away, but has not ruled out a hostile bid in the $100 billion-plus takeover fight.

  • See You Later? Slim Pfizer Deal Hopes Prop Up AstraZeneca

    Pfizer's chances of striking a deal to buy AstraZeneca in the coming days look vanishingly small, but the notion it could return later this year is propping up the British drugmaker's shares. The stock rose 3 percent on Wednesday, despite AstraZeneca insisting on Tuesday there wasn't the slightest chance of Pfizer's $118 billion offer being increased by a May 26 deadline set by UK takeover rules.

Other Advice Videos

  • Andrew Hutson on Finding Sources for Life Advice and Career Coaching

    In Chapter 19 of 23 in his 2014 Capture Your Flag interview, environmental advocate Andrew Hutson answers "At This Moment in Your Life, Where Are You Seeking Advice and Coaching?" Hutson shares three resources he uses for advice and coaching. First and foremost, he relies on his wife for advice giving and attentive listening. Second, he builds mentor relationships in and out of work to provide role modeling and feedback. Third, he works with an executive coach to gain insight on management.

  • Jason Anello on How to Give Better Advice When Asked for Help

    In Chapter 13 of 20 in his 2014 Capture Your Flag interview, creative director and marketing agency co-founder Jason Anello answers "How Have You Learned to Give Better Advice When People Ask You for Help?" Anello shares how giving better advice is to spend more time truly understanding the question you are asked rather than simply sharing what you did when faced with a similar situation. He finds putting himself in the other person's shoes - showing empathy - helps the advice conversation.

  • Mike Germano on How to Give Better Advice When Asked for Help

    In Chapter 20 of 23 in his 2014 Capture Your Flag interview, VICE Media Chief Digital Officer Mike Germano answers "How Have You Learned to Give Better Advice When People Ask You For Help?" Germano shares how advice requests can often be asks for other things, including asking for money. He also learns to know when not to give advice - including unsolicited advice - and instead help others make their own decisions. Mike Germano is Chief Digital Officer at VICE Media.

  • Cathy Erway on Resisting Temptation When Asked for Advice

    In Chapter 17 of 20 in her 2014 Capture Your Flag interview, author and food writer Cathy Erway answers "How Have You Learned to Give Better Advice When People Ask You for Help?" Erway shares how it is important to resist temptation to give advice on topics where you may have a personal agenda. Instead, she finds it better to be patient and try to filter away personal or selfish bias to focus on the person asking for advice. Cathy Erway is an author, food writer, copywriter and radio show host.

  • Phil McKenzie on How to Give Better Advice When Asked for Help

    In Chapter 18 of 20 in his 2014 Capture Your Flag interview, entrepreneur Phil McKenzie answers "How Have You Learned to Give Better Advice When People Ask You For Help?" McKenzie prefaces his willingness to give advice with the fact that knowledge he shares is based on his own circumstances experience. This brings context to the conversation and prevents him from coming across as judgmental or biased. Philip L. McKenzie is the Founder of Influencer Conference, a global content platform.

  • Jullien Gordon on How to Give Better Advice When Asked for Help

    In Chapter 14 of 19 in his 2014 Capture Your Flag interview, business coach and public speaker Jullien Gordon answers "How Have You Learned to Give Better Advice When People Ask You For Help?" When asked for advice, Gordon finds it helpful to start by asking questions and not giving answers. This helps him shift his model for personal development from a "let me teach it to you" approach to providing others space to come up with their own answers. Jullien Gordon is a business coach & consultant.

  • My Advice to Women

    My Advice to Women

  • Anatole Faykin on The Privilege and Pleasure of Giving Advice to Friends

    In Chapter 5 of 16 in his 2014 Capture Your Flag interview, Internet entrepreneur Anatole Faykin answers "How Have You Learned to Give Better Advice When People Ask You For Help?" Faykin shares how giving friends' advice is both a privilege and a pleasure. He notes that giving advice is tough, as often a friend is looking to have a listener and to vent rather to actively seek out feedback. Faykin works to discern those who want to vent from those who actually want advice and answers.